158 related articles for article (PubMed ID: 33096279)
1. Cause-Specific Survival After Meningioma Surgery: A Nationwide Population-Based Competing Risk Study.
Champeaux-Depond C; Constantinou P; Weller J
World Neurosurg; 2021 Feb; 146():e67-e75. PubMed ID: 33096279
[TBL] [Abstract][Full Text] [Related]
2. Five-year cause-specific survival after meningioma surgery. A nationwide population-based study.
Champeaux-Depond C; Weller J; Constantinou P; Tuppin P; Froelich S
Neurochirurgie; 2022 Apr; 68(3):280-288. PubMed ID: 34906556
[TBL] [Abstract][Full Text] [Related]
3. Neurofibromatosis type 2: A nationwide population-based study focused on survival after meningioma surgery.
Champeaux-Depond C; Weller J; Resche-Rigon M
Clin Neurol Neurosurg; 2020 Nov; 198():106236. PubMed ID: 33002675
[TBL] [Abstract][Full Text] [Related]
4. A nationwide population-based study on overall survival after meningioma surgery.
Champeaux-Depond C; Weller J; Froelich S; Resche-Rigon M
Cancer Epidemiol; 2021 Feb; 70():101875. PubMed ID: 33360358
[TBL] [Abstract][Full Text] [Related]
5. Intracranial WHO grade I meningioma: a competing risk analysis of progression and disease-specific survival.
Champeaux C; Houston D; Dunn L; Resche-Rigon M
Acta Neurochir (Wien); 2019 Nov; ():. PubMed ID: 31707459
[TBL] [Abstract][Full Text] [Related]
6. Tamoxifen. A treatment for meningioma?
Champeaux-Depond C; Weller J
Cancer Treat Res Commun; 2021; 27():100343. PubMed ID: 33647870
[TBL] [Abstract][Full Text] [Related]
7. Relative survival after meningioma surgery. A French nationwide population-based cohort study.
Champeaux-Depond C; Constantinou P; Tuppin P; Resche-Rigon M; Weller J
Br J Neurosurg; 2022 Dec; ():1-7. PubMed ID: 36576058
[TBL] [Abstract][Full Text] [Related]
8. Clinical Outcome, Tumor Recurrence, and Causes of Death: A Long-Term Follow-Up of Surgically Treated Meningiomas.
de Almeida AN; Pereira BJA; Pires Aguiar PH; Paiva WS; Cabrera HN; da Silva CC; Teixeira MJ; Marie SKN
World Neurosurg; 2017 Jun; 102():139-143. PubMed ID: 28300708
[TBL] [Abstract][Full Text] [Related]
9. Utility of Neuronavigation in Intracranial Meningioma Resection: A Single-Center Retrospective Study.
Bir SC; Konar SK; Maiti TK; Thakur JD; Guthikonda B; Nanda A
World Neurosurg; 2016 Jun; 90():546-555.e1. PubMed ID: 26805681
[TBL] [Abstract][Full Text] [Related]
10. Extent of resection and overall survival for patients with atypical and malignant meningioma.
Aizer AA; Bi WL; Kandola MS; Lee EQ; Nayak L; Rinne ML; Norden AD; Beroukhim R; Reardon DA; Wen PY; Al-Mefty O; Arvold ND; Dunn IF; Alexander BM
Cancer; 2015 Dec; 121(24):4376-81. PubMed ID: 26308667
[TBL] [Abstract][Full Text] [Related]
11. Cyproterone acetate and meningioma: a nationwide-wide population based study.
Champeaux-Depond C; Weller J; Froelich S; Sartor A
J Neurooncol; 2021 Jan; 151(2):331-338. PubMed ID: 33394263
[TBL] [Abstract][Full Text] [Related]
12. Surgery for convexity meningioma: Simpson Grade I resection as the goal: clinical article.
Hasseleid BF; Meling TR; Rønning P; Scheie D; Helseth E
J Neurosurg; 2012 Dec; 117(6):999-1006. PubMed ID: 23061394
[TBL] [Abstract][Full Text] [Related]
13. Atypical meningioma. A study on recurrence and disease-specific survival.
Champeaux C; Houston D; Dunn L
Neurochirurgie; 2017 Sep; 63(4):273-281. PubMed ID: 28882609
[TBL] [Abstract][Full Text] [Related]
14. Craniotomy for meningioma in the United States between 1988 and 2000: decreasing rate of mortality and the effect of provider caseload.
Curry WT; McDermott MW; Carter BS; Barker FG
J Neurosurg; 2005 Jun; 102(6):977-86. PubMed ID: 16028755
[TBL] [Abstract][Full Text] [Related]
15. Clinical and histopathological predictors of outcome in malignant meningioma.
Maier AD; Bartek J; Eriksson F; Ugleholdt H; Juhler M; Broholm H; Mathiesen TI
Neurosurg Rev; 2020 Apr; 43(2):643-653. PubMed ID: 30868425
[TBL] [Abstract][Full Text] [Related]
16. Impact of postoperative radiotherapy on recurrence of primary intracranial atypical meningiomas.
Keric N; Kalasauskas D; Freyschlag CF; Gempt J; Misch M; Poplawski A; Lange N; Ayyad A; Thomé C; Vajkoczy P; Meyer B; Ringel F
J Neurooncol; 2020 Jan; 146(2):347-355. PubMed ID: 31900826
[TBL] [Abstract][Full Text] [Related]
17. Long-term survival analysis of atypical meningiomas: survival rates, prognostic factors, operative and radiotherapy treatment.
Hammouche S; Clark S; Wong AH; Eldridge P; Farah JO
Acta Neurochir (Wien); 2014 Aug; 156(8):1475-81. PubMed ID: 24965072
[TBL] [Abstract][Full Text] [Related]
18. Surgical Outcomes and Predictors of Recurrence in Elderly Patients with Meningiomas.
Bir SC; Konar S; Maiti TK; Guthikonda B; Nanda A
World Neurosurg; 2016 Jun; 90():251-261. PubMed ID: 26915700
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Factors, Survival, and Treatment for Intracranial World Health Organization Grade II Chordoid Meningiomas and Clear-Cell Meningiomas.
Zhang GJ; Zhang YS; Zhang GB; Yan XJ; Li CB; Zhang LW; Li D; Wu Z; Zhang JT
World Neurosurg; 2018 Sep; 117():e57-e66. PubMed ID: 29859361
[TBL] [Abstract][Full Text] [Related]
20. World Health Organization grade III meningiomas. A retrospective study for outcome and prognostic factors assessment.
Champeaux C; Jecko V
Neurochirurgie; 2016 Aug; 62(4):203-8. PubMed ID: 27339832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
